Use of IL-20 antagonists for treating liver diseases

Ming-Shi Chang

Use of IL-20 antagonists for treating liver diseases

Ming-Shi Chang (Inventor)

生物化學暨分子生物學研究所

研究成果: Patent

摘要

Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

原文	English
專利號	8603470
出版狀態	Published - 1800

引用此

@misc{57b9581a97fb4dd8b46f95424c1d9cec,

title = "Use of IL-20 antagonists for treating liver diseases",

abstract = "Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.",

author = "Ming-Shi Chang",

year = "1800",

language = "English",

type = "Patent",

note = "8603470",

}

TY - PAT

T1 - Use of IL-20 antagonists for treating liver diseases

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

AB - Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

M3 - Patent

M1 - 8603470

ER -

Use of IL-20 antagonists for treating liver diseases

摘要

指紋

引用此